Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells
AUTOR(ES)
Jensen, Lars H
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=545072Documentos Relacionados
- Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187
- Anti-cancer organization.
- Novobiocin inhibits initiation of RNA polymerase II-directed transcription of the mouse metallothionein-I gene independent of its effect on DNA topoisomerase II.
- Isolation of stable preinitiation, initiation, and elongation complexes from RNA polymerase II-directed transcription.
- A screen to identify drug resistant variants to target-directed anti-cancer agents